Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.

Preoperative chemoradiation significantly improves oncological outcome in locally advanced rectal cancer. However there is no effective method of predicting tumor response to chemoradiation in these patients. Peripheral blood mononuclear cells have emerged recently as pathology markers of cancer and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pablo Palma, Marta Cuadros, Raquel Conde-Muíño, Carmen Olmedo, Carlos Cano, Inmaculada Segura-Jiménez, Armando Blanco, Pablo Bueno, J Antonio Ferrón, Pedro Medina
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/64ef766b73284feba126d0f6da8bab1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:64ef766b73284feba126d0f6da8bab1a
record_format dspace
spelling oai:doaj.org-article:64ef766b73284feba126d0f6da8bab1a2021-11-18T08:56:39ZMicroarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.1932-620310.1371/journal.pone.0074034https://doaj.org/article/64ef766b73284feba126d0f6da8bab1a2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24040155/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Preoperative chemoradiation significantly improves oncological outcome in locally advanced rectal cancer. However there is no effective method of predicting tumor response to chemoradiation in these patients. Peripheral blood mononuclear cells have emerged recently as pathology markers of cancer and other diseases, making possible their use as therapy predictors. Furthermore, the importance of the immune response in radiosensivity of solid organs led us to hypothesized that microarray gene expression profiling of peripheral blood mononuclear cells could identify patients with response to chemoradiation in rectal cancer. Thirty five 35 patients with locally advanced rectal cancer were recruited initially to perform the study. Peripheral blood samples were obtained before neaodjuvant treatment. RNA was extracted and purified to obtain cDNA and cRNA for hybridization of microarrays included in Human WG CodeLink bioarrays. Quantitative real time PCR was used to validate microarray experiment data. Results were correlated with pathological response, according to Mandard´s criteria and final UICC Stage (patients with tumor regression grade 1-2 and downstaging being defined as responders and patients with grade 3-5 and no downstaging as non-responders). Twenty seven out of 35 patients were finally included in the study. We performed a multiple t-test using Significance Analysis of Microarrays, to find those genes differing significantly in expression, between responders (n = 11) and non-responders (n = 16) to CRT. The differently expressed genes were: BC 035656.1, CIR, PRDM2, CAPG, FALZ, HLA-DPB2, NUPL2, and ZFP36. The measurement of FALZ (p = 0.029) gene expression level determined by qRT-PCR, showed statistically significant differences between the two groups. Gene expression profiling reveals novel genes in peripheral blood samples of mononuclear cells that could predict responders and non-responders to chemoradiation in patients with locally advanced rectal cancer. Moreover, our investigation added further evidence to the importance of mononuclear cells' mediated response in the neoadjuvant treatment of rectal cancer.Pablo PalmaMarta CuadrosRaquel Conde-MuíñoCarmen OlmedoCarlos CanoInmaculada Segura-JiménezArmando BlancoPablo BuenoJ Antonio FerrónPedro MedinaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74034 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pablo Palma
Marta Cuadros
Raquel Conde-Muíño
Carmen Olmedo
Carlos Cano
Inmaculada Segura-Jiménez
Armando Blanco
Pablo Bueno
J Antonio Ferrón
Pedro Medina
Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
description Preoperative chemoradiation significantly improves oncological outcome in locally advanced rectal cancer. However there is no effective method of predicting tumor response to chemoradiation in these patients. Peripheral blood mononuclear cells have emerged recently as pathology markers of cancer and other diseases, making possible their use as therapy predictors. Furthermore, the importance of the immune response in radiosensivity of solid organs led us to hypothesized that microarray gene expression profiling of peripheral blood mononuclear cells could identify patients with response to chemoradiation in rectal cancer. Thirty five 35 patients with locally advanced rectal cancer were recruited initially to perform the study. Peripheral blood samples were obtained before neaodjuvant treatment. RNA was extracted and purified to obtain cDNA and cRNA for hybridization of microarrays included in Human WG CodeLink bioarrays. Quantitative real time PCR was used to validate microarray experiment data. Results were correlated with pathological response, according to Mandard´s criteria and final UICC Stage (patients with tumor regression grade 1-2 and downstaging being defined as responders and patients with grade 3-5 and no downstaging as non-responders). Twenty seven out of 35 patients were finally included in the study. We performed a multiple t-test using Significance Analysis of Microarrays, to find those genes differing significantly in expression, between responders (n = 11) and non-responders (n = 16) to CRT. The differently expressed genes were: BC 035656.1, CIR, PRDM2, CAPG, FALZ, HLA-DPB2, NUPL2, and ZFP36. The measurement of FALZ (p = 0.029) gene expression level determined by qRT-PCR, showed statistically significant differences between the two groups. Gene expression profiling reveals novel genes in peripheral blood samples of mononuclear cells that could predict responders and non-responders to chemoradiation in patients with locally advanced rectal cancer. Moreover, our investigation added further evidence to the importance of mononuclear cells' mediated response in the neoadjuvant treatment of rectal cancer.
format article
author Pablo Palma
Marta Cuadros
Raquel Conde-Muíño
Carmen Olmedo
Carlos Cano
Inmaculada Segura-Jiménez
Armando Blanco
Pablo Bueno
J Antonio Ferrón
Pedro Medina
author_facet Pablo Palma
Marta Cuadros
Raquel Conde-Muíño
Carmen Olmedo
Carlos Cano
Inmaculada Segura-Jiménez
Armando Blanco
Pablo Bueno
J Antonio Ferrón
Pedro Medina
author_sort Pablo Palma
title Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
title_short Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
title_full Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
title_fullStr Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
title_full_unstemmed Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
title_sort microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/64ef766b73284feba126d0f6da8bab1a
work_keys_str_mv AT pablopalma microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT martacuadros microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT raquelcondemuino microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT carmenolmedo microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT carloscano microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT inmaculadasegurajimenez microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT armandoblanco microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT pablobueno microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT jantonioferron microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
AT pedromedina microarrayprofilingofmononuclearperipheralbloodcellsidentifiesnovelcandidategenesrelatedtochemoradiationresponseinrectalcancer
_version_ 1718421143934730240